Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be

A significant proportion of patients with interstitial lung disease (ILD) may develop a progressive fibrosing phenotype characterized by worsening of symptoms and pulmonary function, progressive fibrosis on chest computed tomography and increased mortality. The clinical course in these patients mimi...

Descripción completa

Detalles Bibliográficos
Autores principales: Goos, Tinne, De Sadeleer, Laurens J., Yserbyt, Jonas, Verleden, Geert M., Vermant, Marie, Verleden, Stijn E., Wuyts, Wim A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004662/
https://www.ncbi.nlm.nih.gov/pubmed/33807034
http://dx.doi.org/10.3390/jcm10061330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004662/
https://www.ncbi.nlm.nih.gov/pubmed/33807034
http://dx.doi.org/10.3390/jcm10061330

Ejemplares similares